1. Home
  2. AKRO vs UPWK Comparison

AKRO vs UPWK Comparison

Compare AKRO & UPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • UPWK
  • Stock Information
  • Founded
  • AKRO 2017
  • UPWK 2013
  • Country
  • AKRO United States
  • UPWK United States
  • Employees
  • AKRO N/A
  • UPWK N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • UPWK EDP Services
  • Sector
  • AKRO Health Care
  • UPWK Technology
  • Exchange
  • AKRO Nasdaq
  • UPWK Nasdaq
  • Market Cap
  • AKRO 2.0B
  • UPWK 2.3B
  • IPO Year
  • AKRO 2019
  • UPWK 2018
  • Fundamental
  • Price
  • AKRO $25.14
  • UPWK $16.89
  • Analyst Decision
  • AKRO Strong Buy
  • UPWK Strong Buy
  • Analyst Count
  • AKRO 8
  • UPWK 11
  • Target Price
  • AKRO $46.83
  • UPWK $18.09
  • AVG Volume (30 Days)
  • AKRO 842.7K
  • UPWK 1.9M
  • Earning Date
  • AKRO 02-27-2025
  • UPWK 02-12-2025
  • Dividend Yield
  • AKRO N/A
  • UPWK N/A
  • EPS Growth
  • AKRO N/A
  • UPWK N/A
  • EPS
  • AKRO N/A
  • UPWK 0.62
  • Revenue
  • AKRO N/A
  • UPWK $761,776,000.00
  • Revenue This Year
  • AKRO N/A
  • UPWK $12.35
  • Revenue Next Year
  • AKRO N/A
  • UPWK $2.88
  • P/E Ratio
  • AKRO N/A
  • UPWK $27.20
  • Revenue Growth
  • AKRO N/A
  • UPWK 14.27
  • 52 Week Low
  • AKRO $15.32
  • UPWK $8.43
  • 52 Week High
  • AKRO $37.00
  • UPWK $18.14
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 41.89
  • UPWK 56.72
  • Support Level
  • AKRO $21.34
  • UPWK $15.19
  • Resistance Level
  • AKRO $28.94
  • UPWK $17.18
  • Average True Range (ATR)
  • AKRO 1.38
  • UPWK 0.57
  • MACD
  • AKRO -0.27
  • UPWK -0.00
  • Stochastic Oscillator
  • AKRO 49.67
  • UPWK 85.43

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

About UPWK Upwork Inc.

Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.

Share on Social Networks: